Diffuse Malignant Pleural Mesothelioma

Dissipate malignant pleural mesothelioma, or DMM, is an exceptional but highly aggressive type of cancer. It occurs in the thin part of tissue, the pl?k?n?, lining the chest tooth cavity and lungs.

Once clinically diagnosed with DMM, most patients do not survive further than one year. This malignancy is more common in men than in women, and in seniors.

Many people with DMM have a history of publicity to asbestos; however, if they are not aware that such exposure took place, they are often unaware that they are at risk.

An individual with DMM typically has one or more of the following signs or symptoms: breasts pain, shortness of breath of air, unexplained weight loss, exhaustion, fever, or a coughing.


An x-ray usually shows that the pleural cells around the lungs has thickened due to the development of many of nodules or small malignant growths. Sometimes, there may be an individual large progress.

When a biopsy of the cancer tissue is done, the types of cells that comprise the cancer may be epithelioid, mixed, or sarcomatoid. Persons with epithelioid cell malignancies tend to survive to some degree longer; those with sarcomatoid cancers normally have the least survival.

DMM is always treated as aggressively as possible.


 The type of treatment will depend on the prominent cell type the cancers is made of, the extent of spread of the cancer, and the general health of the person undergoing treatment. Surgery is a preferred option where the almost all the cancer can be removed.

 Many anti-cancer drugs are being tried to treat DMM, with varying levels of short-term success. Radiosurgery and radiotherapy may also be an option.


Many clinical tests are currently underway in an attempt to find a treatment that may increase the outlook for DMM patients. However, only seven percent of men and women with DMM survive beyond five years.